A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
Jesus Campagna(University of California, Los Angeles), Varghese John(University of California, Los Angeles), Asa Hatami(University of California, Los Angeles), Barbara Jagodzinska(University of California, Los Angeles), Tina Bilousova(University of California, Los Angeles), Mary Jo LaDu(University of Illinois Chicago), Michael E. Jung(University of California, Los Angeles), Michael Jun(University of California, Los Angeles), Dongsheng Bai(Beijing Technology and Business University), Patricia Spilman, Gregory M. Cole(University of California, Los Angeles), Dale E. Bredesen(University of California, Los Angeles), Chris Jean Elias(University of California, Los Angeles), Johnny D. Pham(University of California, Los Angeles), Chunni Zhu(University of California, Los Angeles)
Cited by 36
Related Papers
Coupling endoplasmic reticulum stress to the cell death program
|Cell Death and Differentiation|2004|1.2k
Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain
|Journal of Neurochemistry|2001|879
Ayurvedic medicinal plants for Alzheimer's disease: a review
|Alzheimer s Research & Therapy|2012|212
Human β-Secretase (BACE) and BACE Inhibitors
|Journal of Medicinal Chemistry|2003|146